一名接受西罗莫司治疗的丙型肝炎阳性同种异体移植受者发生移植后晚期红细胞增多症。
Late post-transplant erythrocytosis in a hepatitis C-positive allograft recipient on sirolimus.
作者信息
Ali A A M, Khanna P, Mehrotra A, Abraham G
机构信息
Department of Nephrology, Chennai Transplant Centre, Madras Medical Mission Hospital, Chennai, India.
出版信息
Indian J Nephrol. 2011 Apr;21(2):126-7. doi: 10.4103/0971-4065.82142.
Hematological complications in renal transplant recipients include anemia, leukopenia, and post-transplant erythrocytosis (PTE). There are numerous causes for these which include immunosuppressive drugs, viral infections, etc. We report here a hepatitis C (HCV)-positive case who developed PTE while receiving rapamycin. As both HCV infection and rapamycin through different mechanisms can produce anemia, this case report highlights the rarity of erythrocytosis.
肾移植受者的血液学并发症包括贫血、白细胞减少症和移植后红细胞增多症（PTE）。这些并发症有多种原因，包括免疫抑制药物、病毒感染等。我们在此报告一例丙型肝炎病毒（HCV）阳性患者，在接受雷帕霉素治疗期间发生了PTE。由于HCV感染和雷帕霉素通过不同机制均可导致贫血，本病例报告凸显了红细胞增多症的罕见性。
Zotero 插件